Fact CheckerSign in

NCT06913712Recruiting

BMI in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment

Evolution of Body Mass Index in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment. Retrospective and Prospective Study

Source: ClinicalTrials.gov · Last updated 22 Apr 2026

Brief summary (registry, in English)

1. To establish the correlation between the evolution of the body mass index in benign intracranial hypertension and the response to treatments. 2. To establish the BMI at which this disease occurs. 3. To establish how much the BMI must be reduced to cure this disease. 4. To assess the evolution and response to treatments of sick people who DO NOT reduce or even continue to increase their BMI despite treatment with Acetazolamide or a possible CSF diversion

Status (registry)
Recruiting
Study type
Observational
Enrollment
25 (estimated)
First submitted
12 Jan 2025
Start date
27 Jun 2024
Primary completion date
1 May 2028
Lead sponsor
University of Valencia
NCT number
NCT06913712

What you commit to

  • Study type: Observational
  • Planned participants: 25
  • From 27 Jun 2024 to the primary completion date, 1 May 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • A diagnosis other than IIH, specifically: tension-type headache, Chiari I malformation, or any other headache disorder unrelated to IIH.
  • The presence of secondary causes of increased intracranial pressure (e.g., structural brain abnormalities, venous sinus thrombosis, or medication-induced factors).

Who the study is looking for

  • Adults aged 18 years and older at the time of enrollment. There is no upper age limit to ensure inclusivity across age ranges.
  • A confirmed diagnosis of Idiopathic Intracranial Hypertension, established according to the Dandy criteria.
  • The diagnostic process must exclude other potential causes of increased intracranial pressure as detailed in the 'Diagnosis' section, ensuring an accurate identification of idiopathic cases.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Consorcio Hospital General Universitario de Valencia
Coordinator of this site? Confirm its status
ValenciaSpainRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.